221 related articles for article (PubMed ID: 28268188)
1.
Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
[TBL] [Abstract][Full Text] [Related]
2. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Quansah E; Zetterström TSC
Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
[TBL] [Abstract][Full Text] [Related]
3. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence.
Adriani W; Canese R; Podo F; Laviola G
Neurotoxicol Teratol; 2007; 29(1):116-25. PubMed ID: 17196789
[TBL] [Abstract][Full Text] [Related]
4. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
Hammerness P; Biederman J; Petty C; Henin A; Moore CM
CNS Neurosci Ther; 2012 Jan; 18(1):34-40. PubMed ID: 21143432
[TBL] [Abstract][Full Text] [Related]
5. Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD.
Miller EM; Quintero JE; Pomerleau F; Huettl P; Gerhardt GA; Glaser PEA
Neurochem Res; 2019 Jan; 44(1):89-101. PubMed ID: 29397534
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum.
Chase TD; Carrey N; Brown RE; Wilkinson M
Brain Res Dev Brain Res; 2005 Jun; 157(2):181-91. PubMed ID: 15916815
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats.
Quansah E; Ruiz-Rodado V; Grootveld M; Zetterström TSC
Eur Neuropsychopharmacol; 2018 Apr; 28(4):513-528. PubMed ID: 29478746
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics study of the prefrontal cortex in a rat model of attention deficit hyperactivity disorder reveals the association between cholesterol metabolism disorder and hyperactive behavior.
Chen T; Yuan H; Sun YB; Song YC; Lu M; Ni X; Han X
Biochem Biophys Res Commun; 2020 Mar; 523(2):315-321. PubMed ID: 31864712
[TBL] [Abstract][Full Text] [Related]
9. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring.
Panos JJ; Law CD; Ferguson SA
Neurotoxicol Teratol; 2014; 42():9-16. PubMed ID: 24444667
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients.
Solleveld MM; Schrantee A; Puts NAJ; Reneman L; Lucassen PJ
Neuroimage Clin; 2017; 15():812-818. PubMed ID: 28725548
[TBL] [Abstract][Full Text] [Related]
11. Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
Unal GA; Kenar AN; Herken H; Kiroglu Y
Neurosci Lett; 2015 Sep; 604():188-92. PubMed ID: 26257254
[TBL] [Abstract][Full Text] [Related]
12. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
Zetterström TSC; Quansah E; Grootveld M
Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
[TBL] [Abstract][Full Text] [Related]
13. The effect of single-dose methylphenidate on resting-state network functional connectivity in ADHD.
Silk TJ; Malpas C; Vance A; Bellgrove MA
Brain Imaging Behav; 2017 Oct; 11(5):1422-1431. PubMed ID: 27734305
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Ünal GA; İnci Kenar AN; Tepeli E; Kıroğlu Y; Herken H
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2443-9. PubMed ID: 27338073
[TBL] [Abstract][Full Text] [Related]
16. Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats.
Panos JJ; O'Callaghan JP; Miller DB; Ferguson SA
Neurotoxicol Teratol; 2014; 45():70-4. PubMed ID: 25132048
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of methylphenidate after long-term exposure in nonhuman primates.
Zhang X; Berridge MS; Apana SM; Slikker W; Paule MG; Talpos J
Neurotoxicol Teratol; 2023; 97():107173. PubMed ID: 36893929
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate increases creatine kinase activity in the brain of young and adult rats.
Scaini G; Fagundes AO; Rezin GT; Gomes KM; Zugno AI; Quevedo J; Streck EL
Life Sci; 2008 Dec; 83(23-24):795-800. PubMed ID: 18938183
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder.
Battel L; Kieling RR; Kieling C; Anés M; Aurich NK; da Costa JC; Rohde LA; Franco AR
J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):555-61. PubMed ID: 27027427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
